{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T06:26:01Z","timestamp":1762410361042,"version":"3.38.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.pcad.2024.12.007","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T16:55:30Z","timestamp":1735577730000},"page":"105-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The efficacy of revascularization in ischemic cardiomyopathy"],"prefix":"10.1016","volume":"88","author":[{"given":"Kais","family":"Hyasat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieh-Shou","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay J.","family":"Kirtane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"McEntegart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pcad.2024.12.007_bb0005","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ejhf.1747","article-title":"Ischaemic cardiomyopathy. Pathophysiological insights, diagnostic management and the roles of revascularisation and device treatment. Gaps and dilemmas in the era of advanced technology","volume":"22","author":"Cabac-Pogorevici","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.pcad.2024.12.007_bb0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0735-1097(01)01738-7","article-title":"A standardized definition of ischemic cardiomyopathy for use in clinical research","volume":"39","author":"Felker","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2024.12.007_bb0015","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0735-1097(97)00235-0","article-title":"Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy","volume":"30","author":"Bart","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2024.12.007_bb0020","article-title":"Ischemic cardiomyopathy versus non-ischemic dilated cardiomyopathy in patients with reduced ejection fraction- clinical characteristics and prognosis depending on heart failure etiology (data from European Society of Cardiology Heart Failure Registries)","volume":"11","author":"Tymi\u0144ska","year":"2022","journal-title":"Biology (Basel)"},{"issue":"8","key":"10.1016\/j.pcad.2024.12.007_bb0025","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0002-9149(02)02704-2","article-title":"Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock","volume":"90","author":"Dauerman","year":"2002","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2024.12.007_bb0030","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic SHOCK. SHOCK investigators. Should we emergently Revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.pcad.2024.12.007_bb0035","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","article-title":"Complete revascularization with multivessel PCI for myocardial infarction","volume":"381","author":"Mehta","year":"2019","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.pcad.2024.12.007_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028475","article-title":"Impact of complete revascularization on development of heart failure in patients with acute coronary syndrome and multivessel disease: A subanalysis of the CORALYS registry","volume":"12","author":"Bruno","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.pcad.2024.12.007_bb0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/eurheartj\/ehac794","article-title":"Revascularization in ischaemic cardiomyopathy: how to interpret current evidence","volume":"44","author":"Gersh","year":"2023","journal-title":"Eur Heart J"},{"issue":"12 Suppl 1","key":"10.1016\/j.pcad.2024.12.007_bb0050","doi-asserted-by":"crossref","first-page":"I314","DOI":"10.1161\/hc37t1.094853","article-title":"Time course of functional recovery of stunned and hibernating segments after surgical revascularization","volume":"104","author":"Bax","year":"2001","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.pcad.2024.12.007_bb0055","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2024.12.007_bb0060","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijcard.2015.01.025","article-title":"Myocardial viability for decision-making concerning revascularization in patients with left ventricular dysfunction and coronary artery disease: a meta-analysis of non-randomized and randomized studies","volume":"182","author":"Orlandini","year":"2015","journal-title":"Int J Cardiol"},{"issue":"17","key":"10.1016\/j.pcad.2024.12.007_bb0065","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.pcad.2024.12.007_bb0070","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.pcad.2024.12.007_bb0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jacc.2014.04.064","article-title":"Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [corrected]","volume":"64","author":"Panza","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"8922","key":"10.1016\/j.pcad.2024.12.007_bb0080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(94)91963-1","article-title":"Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the coronary artery bypass graft surgery Trialists collaboration","volume":"344","author":"Yusuf","year":"1994","journal-title":"Lancets"},{"issue":"15","key":"10.1016\/j.pcad.2024.12.007_bb0085","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.pcad.2024.12.007_bb0090","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the Management of Heart Failure: A report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2024.12.007_bb0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/eurjhf\/hfq230","article-title":"The HEART failure revascularisation trial (HEART)","volume":"13","author":"Cleland","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.pcad.2024.12.007_bb0100","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0197-2456(03)00106-5","article-title":"Evaluation of outcome and cost-effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rationale, design, and methods","volume":"24","author":"Beanlands","year":"2003","journal-title":"Control Clin Trials"},{"issue":"9","key":"10.1016\/j.pcad.2024.12.007_bb0105","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jcmg.2009.02.017","article-title":"Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial","volume":"2","author":"D\u2019Egidio","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"issue":"17","key":"10.1016\/j.pcad.2024.12.007_bb0110","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1100358","article-title":"Myocardial viability and survival in ischemic left ventricular dysfunction","volume":"364","author":"Bonow","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.pcad.2024.12.007_bb0115","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamacardio.2023.3803","article-title":"Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction: A Prespecified secondary analysis of the REVIVED-BCIS2 trial","volume":"8","author":"Perera","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2024.12.007_bb0120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCULATIONAHA.120.050734","article-title":"Association of Inducible Myocardial Ischemia with Long-Term Mortality and Benefit from Coronary Artery Bypass Graft Surgery in ischemic cardiomyopathy: ten-year follow-up of the STICH trial","volume":"143","author":"O\u2019Fee","year":"2021","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.pcad.2024.12.007_bb0125","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/CIRCULATIONAHA.120.049755","article-title":"Outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity","volume":"144","author":"Reynolds","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2024.12.007_bb0130","first-page":"45","article-title":"The prognostic impact of inducible ischemia in severe ischaemic cardiomyopathy: a randomised comparison of medical therapy and revascularisation","author":"Morgan","year":"2024","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.pcad.2024.12.007_bb0135","article-title":"Left ventricular ejection fraction change following percutaneous coronary intervention: correlates and association with prognosis","volume":"13","author":"Ndrepepa","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.pcad.2024.12.007_bb0140","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jacc.2024.04.043","article-title":"Impact of anatomical and viability-guided completeness of revascularization on clinical outcomes in ischemic cardiomyopathy","volume":"84","author":"Ezad","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.pcad.2024.12.007_bb0145","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0022-5223(03)00809-2","article-title":"Survival after myocardial revascularization for ischemic cardiomyopathy: a prospective ten-year follow-up study","volume":"126","author":"Shah","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"10","key":"10.1016\/j.pcad.2024.12.007_bb0150","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.jcmg.2019.10.021","article-title":"Sudden cardiac death in ischemic heart disease: from imaging Arrhythmogenic substrate to guiding therapies","volume":"13","author":"Gr\u00e4ni","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"13","key":"10.1016\/j.pcad.2024.12.007_bb0155","first-page":"e210","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.pcad.2024.12.007_bb0160","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJM199711273372201","article-title":"Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary artery bypass graft (CABG) patch trial investigators","volume":"337","author":"Bigger","year":"1997","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.pcad.2024.12.007_bb0165","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/CIRCULATIONAHA.123.065300","article-title":"Arrhythmia and death following percutaneous revascularization in ischemic left ventricular dysfunction: Prespecified analyses from the REVIVED-BCIS2 trial","volume":"148","author":"Perera","year":"2023","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.pcad.2024.12.007_bb0170","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.jcin.2017.06.071","article-title":"A new algorithm for crossing chronic Total occlusions from the Asia Pacific chronic Total occlusion Club","volume":"10","author":"Harding","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.pcad.2024.12.007_bb0175","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4244\/EIJ-D-18-00826","article-title":"Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club","volume":"15","author":"Galassi","year":"2019","journal-title":"EuroIntervention"},{"issue":"19","key":"10.1016\/j.pcad.2024.12.007_bb0180","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.jacc.2019.08.1049","article-title":"A novel algorithm for treating chronic Total coronary artery occlusion","volume":"74","author":"Tanaka","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.pcad.2024.12.007_bb0185","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jacc.2021.05.055","article-title":"Global chronic Total occlusion crossing algorithm: JACC state-of-the-art review","volume":"78","author":"Wu","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2024.12.007_bb0190","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ijcard.2012.12.044","article-title":"Predictors of cardiac death in patients with coronary chronic total occlusion not revascularized by PCI","volume":"168","author":"Godino","year":"2013","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.pcad.2024.12.007_bb0195","first-page":"E222","article-title":"Chronic total improvement in ventricular function and survival","volume":"7","author":"Boukhris","year":"2015","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.pcad.2024.12.007_bb0200","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jacc.2014.04.040","article-title":"Long-term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. central cardiac audit database","volume":"64","author":"George","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2024.12.007_bb0205","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12872-021-01976-w","article-title":"The impact of successful chronic total occlusion percutaneous coronary intervention on long-term clinical outcomes in real world","volume":"21","author":"Gong","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"10.1016\/j.pcad.2024.12.007_bb0210","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019022","article-title":"Late survival benefit of percutaneous coronary intervention compared with medical therapy in patients with coronary chronic Total occlusion: A 10-year follow-up study","volume":"10","author":"Park","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.pcad.2024.12.007_bb0215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00392-020-01738-2","article-title":"Differential clinical impact of chronic total occlusion revascularization based on left ventricular systolic function","volume":"110","author":"Kook","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.pcad.2024.12.007_bb0220","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.carrev.2022.03.029","article-title":"Impact of successful chronic coronary Total occlusion recanalization on recurrence of ventricular arrhythmias in implantable cardioverter-defibrillator recipients for ischemic cardiomyopathy (VACTO PCI study)","volume":"43","author":"Iannaccone","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"issue":"4","key":"10.1016\/j.pcad.2024.12.007_bb0225","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ccd.28850","article-title":"Long-term clinical effects of recanalization of chronic coronary total occlusions in patients with left ventricular systolic dysfunction","volume":"96","author":"Pinto","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"issue":"19","key":"10.1016\/j.pcad.2024.12.007_bb0230","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jcin.2018.05.041","article-title":"A randomized trial to assess regional left ventricular function after stent implantation in chronic Total occlusion: the REVASC trial","volume":"11","author":"Mashayekhi","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"15","key":"10.1016\/j.pcad.2024.12.007_bb0235","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jacc.2016.07.744","article-title":"Percutaneous intervention for concurrent chronic Total occlusions in patients with STEMI: the EXPLORE trial","volume":"68","author":"Henriques","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2024.12.007_bb0240","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.ahj.2005.07.017","article-title":"The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase","volume":"151","author":"Ong","year":"2006","journal-title":"Am Heart J"},{"issue":"10260","key":"10.1016\/j.pcad.2024.12.007_bb0245","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(20)32114-0","volume":"396","author":"Takahashi","year":"2020","journal-title":"Lancet"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062024001762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062024001762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T07:00:39Z","timestamp":1740466839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062024001762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":49,"alternative-id":["S0033062024001762"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2024.12.007","relation":{},"ISSN":["0033-0620"],"issn-type":[{"type":"print","value":"0033-0620"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of revascularization in ischemic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2024.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}